Toby Chai Appointed Chief, Chair of Urology

Toby C. Chai, MD, has been named Chief of Urology at Boston Medical Center, and Professor and Chair of the Department of Urology at Boston University School of Medicine. He also will serve as President of Boston University Medical Center Urologists, Inc. Dr. Chai will join us on August 1, 2019.

Currently, Dr. Chai is Professor of Urology and Obstetrics, Gynecology, and Reproductive Sciences at Yale University School of Medicine. He serves as Vice Chair of Research in the Department of Urology and Co-Director of the Female Pelvic Medicine and Reconstructive Surgery Program at Yale New Haven Hospital.

Dr. Chai completed his medical degree at Indiana University School of Medicine, his urology residency at University of Michigan Medical Center, and a fellowship at University of Virginia. Prior to joining Yale, he held the John D. Young Professorship in Urology at the University of Maryland School of Medicine.

He has published 150 papers, reviews, and medical texts. He serves on the editorial board of the American Journal of Physiology – Renal, and is Co-Editor-in-Chief of Bladder and Associate Editor for Journal of Urology. His peers have recognized his significant contributions to the field by honoring him with the American Urological Association’s Victor A. Politano Award for outstanding work in treatment of urinary incontinence and innovations in bladder research and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction’s Distinguished Service Award for outstanding contributions to urodynamics, female urology and voiding dysfunction, and exemplary service to the Society.

Many thanks to Richard Babayan, MD, who has served as Chief and Chair for the past 19 years. Dr. Babayan announced his plans last year to step down from the role once a successor was named.

Thanks to David McAneny, MD, Vice Chair of Surgery, who headed the search committee, as well as the other members of the committee for their work to develop a very strong candidate pool. A special thanks to Bill Creevy, MD, President and CEO of Boston University Medical Group, for his contributions to the process.